Gsa Capital Partners LLP 10x Genomics, Inc. Transaction History

Gsa Capital Partners LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$40.86 - $62.98 $1.6 Million - $2.47 Million	39,158 Added 460.36%	47,664 $1.97 Million
Q2 2023 Aug 14, 2023	BUY	$50.96 - $58.72 $433,465 - $499,472	8,506 New	8,506 $474,000
Q4 2022 Feb 13, 2023	BUY	$24.4 - $41.3 $452,620 - $766,115	18,550 New	18,550 $676,000
Q3 2021 Nov 12, 2021	SELL	$145.58 - $192.14 $261,752 - $345,467	-1,798 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$134.22 - $202.37 $241,327 - $363,861	1,798 New	1,798 $352,000
Q1 2021 May 10, 2021	SELL	$140.25 - $196.86 $264,792 - $371,671	-1,888 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$126.47 - $163.7 $30,099 - $38,960	238 Added 14.42%	1,888 $267,000
Q3 2020 Nov 06, 2020	BUY	$87.44 - $125.0 $144,276 - $206,250	1,650 New	1,650 $206,000

285

95.8M

162K

107K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.